Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons™

Open Access. Powered by Scholars. Published by Universities.®

2014

PCOM Physician Assistant Studies Student Scholarship

Alzheimer’s disease

Articles 1 - 1 of 1

Full-Text Articles in Medicine and Health Sciences

Is 30 Ml Cerebrolysin A Safe And Effective Drug For Improving Global And Cognitive Function In Patients With Alzheimer's Disease Aged 50 Years And Older With No Significant Comorbidities?, Anthony Champion Jan 2014

Is 30 Ml Cerebrolysin A Safe And Effective Drug For Improving Global And Cognitive Function In Patients With Alzheimer's Disease Aged 50 Years And Older With No Significant Comorbidities?, Anthony Champion

PCOM Physician Assistant Studies Student Scholarship

OBJECTIVE: The objective of this selective EBM review is to determine whether or not the use of 30 mL Cerebrolysin is a safe and effective drug for improving global and cognitive function in patients with Alzheimer’s Disease aged 50 years and older with no significant comorbidities.

STUDY DESIGN: Systematic review of three randomized controlled trials published between 2001-2006, all English language.

DATA SOURCES: Three randomized controlled trials comparing the efficacy of cerebrolysin to placebo in the treatment of individuals ages 50 and over with AD related cognitive and global functioning decline. All articles found using PubMed.

OUTCOMES MEASURED …

Go to article